Stock listing
LSE:0K6R Neurocrine Biosciences, Inc. Share Price
UK listing (LSE) of Neurocrine Biosciences, Inc. · home listing NASDAQ:NBIX
Follow Neurocrine Biosciences, Inc. into a list and get an email when it puts out news.
Share price · LSE:0K6R
$142.97 USD +1.59 (+1.1%)
Close on Oct 22, 2026
- Day range
- $140.00 – $143.93 USDOct 22, 2026
- Volume
- 313 sharesOct 22, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NBIX · Home | $143.29 USD | +1.98 (+1.4%) | 1,244,530 | $141.62 | $143.83 | $140.75 | $141.31 | Close on Oct 22, 2026 |
| Frankfurt:NB3 | €123.10 EUR | -2.60 (-2.1%) | — | €123.10 | €123.10 | €123.10 | €125.70 | Close on Oct 22, 2026 |
| LSE:0K6R | $142.97 USD | +1.59 (+1.1%) | 313 | $141.00 | $143.93 | $140.00 | $141.38 | Close on Oct 22, 2026 |
| B3:N1BI34 | 35.80 BRL | +0.94 (+2.7%) | 4 | 35.80 | 35.80 | 35.72 | 34.86 | Close on Oct 21, 2026 |
| Munich:NB3 | €125.70 EUR | 0.00 (0.0%) | — | €125.70 | €125.70 | €125.70 | €125.70 | Close on Oct 22, 2026 |
- Ticker
- LSE:0K6R
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
Neurocrine Biosciences Announces Publication in Orphanet Journal of Rare Diseases Advancing Understanding of Hyperphagia in Prader-Willi Syndrome
Latest earnings call · Jul 30, 2026
Neurocrine Biosciences (NASDAQ:NBIX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · May 5, 2026
Q1 2026 Earnings Presentation
Earnings · 15 slides
Calls
Upcoming
Neurocrine Biosciences (NASDAQ:NBIX) Q3 2026 Earnings Call
Mon, Nov 02, 2026 · 4:30 PM ET
Register
Replays
Neurocrine Biosciences (NASDAQ:NBIX) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 4:30 PM ET
Watch TranscriptNeurocrine Biosciences (NASDAQ:NBIX) Q1 2026 Earnings Call
Tue, May 05, 2026 · 4:30 PM ET
Watch TranscriptNeurocrine Biosciences (NASDAQ:NBIX) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Decks
Q1 2026 Earnings Presentation
Earnings · 15 slides · May 5, 2026
Merger or Acquisition (April 2026)
Merger or acquisition · 12 slides · Apr 6, 2026
Q4 2025 Earnings Presentation
Earnings · 71 slides · Feb 11, 2026
Q3 2025 Earnings Presentation
Earnings · 48 slides · Oct 28, 2025
Neurocrine Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 52 in the last 12 months · 275 in all · newest Oct 22, 2026 · oldest 2019
- Calls
- 16 calls with a replay · 16 with a transcript · latest Jul 30, 2026
- Decks
- 7 decks · latest May 5, 2026
Where Neurocrine Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NBIX · Home listing | NASDAQ | United States | USD |
| gettex:NB3 | gettex | Germany | EUR |
| Lang & Schwarz:900964 | Lang & Schwarz | Germany | EUR |
| Frankfurt:NB3 | Frankfurt | Germany | EUR |
| LS Exchange:900964 | LS Exchange | Germany | EUR |
| BMV:NBIX | BMV | Mexico | MXN |
| LSE:0K6R · This page | LSE | United Kingdom | USD |
| B3:N1BI34 | B3 | Brazil | BRL |
| Tradegate:NB3 | Tradegate | Germany | EUR |
| Milan:1NBIX | Milan | Italy | EUR |
| BIVA:NBIX | BIVA | Mexico | MXN |
| BOATS:NBIX | BOATS | United States | USD |
| BX Swiss:NB3 | BX Swiss | Switzerland | CHF |
| Dusseldorf:NB3 | Dusseldorf | Germany | EUR |
| Munich:NB3 | Munich | Germany | EUR |
| Stuttgart:NB3 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Neurocrine Biosciences, Inc.